Free Trial

Kennedy-Wilson (KW) Financials

Kennedy-Wilson logo
$6.36 +0.29 (+4.78%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$6.37 +0.01 (+0.16%)
As of 05/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Kennedy-Wilson

Annual Income Statements for Kennedy-Wilson

This table shows Kennedy-Wilson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
-77 -342 65 313 93 224 150 101 2.80 71 14
Consolidated Net Income / (Loss)
-34 -281 102 336 108 321 212 138 77 59 90
Net Income / (Loss) Continuing Operations
-34 -281 102 336 108 321 212 138 77 59 90
Total Pre-Tax Income
-24 -337 138 463 151 363 270 122 91 112 123
Total Operating Income
229 182 117 293 -54 154 4.30 104 145 128 50
Total Gross Profit
239 233 219 535 193 414 263 286 242 359 228
Total Revenue
531 563 540 843 454 749 772 802 690 604 399
Operating Revenue
531 563 540 843 454 749 772 802 690 604 399
Total Cost of Revenue
292 330 321 308 261 335 510 516 448 245 171
Operating Cost of Revenue
292 330 321 308 261 335 510 516 448 245 171
Total Operating Expenses
10 51 102 242 247 260 259 181 97 231 178
Selling, General & Admin Expense
39 36 37 33 35 42 51 42 45 44 42
Depreciation Expense
148 158 173 166 180 188 206 213 198 166 105
Other Operating Expenses / (Income)
-17 -15 -4.30 42 32 30 - - - 111 80
Other Special Charges / (Income)
-160 -128 -104 - - - - -78 -156 -97 -54
Total Other Income / (Expense), net
-252 -519 21 170 206 209 266 17 -54 -16 73
Interest Expense
263 261 193 46 211 215 238 218 192 157 84
Interest & Investment Income
6.50 -253 178 -192 81 - 79 - - - -46
Other Income / (Expense), net
4.20 -5.00 36 408 336 424 425 235 137 141 204
Income Tax Expense
10 -55 36 126 44 41 58 -16 14 53 32
Preferred Stock Dividends Declared
44 38 29 17 17 2.60 0.00 0.00 2.80 3.60 8.10
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.70 22 8.20 6.00 -2.30 94 62 38 71 -16 68
Basic Earnings per Share
($0.56) ($2.46) $0.47 $2.26 $0.66 $1.60 $1.04 $0.83 $0.01 $0.66 $0.14
Weighted Average Basic Shares Outstanding
137.78M 138.93M 136.90M 138.55M 139.74M 139.73M 142.90M 119.15M 109.09M 103.26M 89.20M
Diluted Earnings per Share
($0.56) ($2.46) $0.47 $2.24 $0.66 $1.58 $1.04 $0.83 $0.01 $0.66 $0.14
Weighted Average Diluted Shares Outstanding
137.78M 138.93M 138.57M 140.13M 140.35M 141.50M 144.75M 119.15M 109.09M 109.55M 91.56M
Weighted Average Basic & Diluted Shares Outstanding
138.01M 138.98M 137.97M 137.87M 141.08M 142.17M 142.98M 151.03M 109.09M 103.26M 89.20M
Cash Dividends to Common per Share
$0.60 $0.96 $0.96 $0.90 $0.88 $0.85 $0.78 $0.70 $0.56 $0.48 $0.36

Quarterly Income Statements for Kennedy-Wilson

This table shows Kennedy-Wilson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-41 33 -77 -59 27 -248 -92 39 -41 23 16
Consolidated Net Income / (Loss)
-30 44 -67 -48 38 -236 -64 47 -29 39 24
Net Income / (Loss) Continuing Operations
-30 44 -67 -48 38 -236 -64 47 -29 39 24
Total Pre-Tax Income
-35 50 -78 -60 64 -278 -84 58 -33 53 38
Total Operating Income
21 186 23 3.70 16 103 54 12 13 -35 22
Total Gross Profit
63 78 59 45 57 46 65 60 63 -102 71
Total Revenue
128 170 128 114 120 152 144 145 122 69 152
Operating Revenue
128 170 128 114 120 152 144 145 122 69 152
Total Cost of Revenue
65 92 69 69 63 107 79 85 59 171 81
Operating Cost of Revenue
65 92 69 69 63 107 79 85 59 171 81
Total Operating Expenses
43 -108 35 41 42 -57 11 48 49 -67 49
Selling, General & Admin Expense
10 11 10 9.50 8.30 10 8.40 8.70 8.40 11 9.20
Depreciation Expense
34 36 37 36 39 40 39 40 39 40 46
Other Operating Expenses / (Income)
-2.70 -1.10 -5.50 -4.50 -5.50 -9.60 -6.00 -1.10 1.60 -15 -6.60
Other Special Charges / (Income)
0.80 - -6.20 - - - -30 - - - -
Total Other Income / (Expense), net
-55 -137 -101 -64 49 -381 -138 46 -46 88 15
Interest Expense
61 195 67 0.50 -0.30 195 64 1.70 -0.10 191 1.30
Interest & Investment Income
11 155 -20 -64 -65 -51 -74 -66 -62 339 -57
Other Income / (Expense), net
-5.20 -96 -13 0.50 113 -135 0.70 113 16 -61 74
Income Tax Expense
-4.90 6.00 -11 -12 27 -42 -20 10 -3.90 14 14
Preferred Stock Dividends Declared
11 11 11 11 11 11 11 8.40 7.90 7.90 7.90
Net Income / (Loss) Attributable to Noncontrolling Interest
0.30 -0.30 -0.20 -0.10 -0.10 1.00 17 -0.10 4.20 8.70 -0.70
Basic Earnings per Share
($0.30) $0.24 ($0.56) ($0.43) $0.19 ($1.78) ($0.66) $0.28 ($0.30) $0.17 $0.12
Weighted Average Basic Shares Outstanding
137.75M 137.78M 137.41M 137.59M 138.47M 138.93M 139.39M 139.39M 137.95M 136.90M 136.84M
Diluted Earnings per Share
($0.30) $0.24 ($0.56) ($0.43) $0.19 ($1.78) ($0.66) $0.28 ($0.30) $0.18 $0.12
Weighted Average Diluted Shares Outstanding
137.75M 137.78M 137.41M 137.59M 138.63M 138.93M 139.39M 139.55M 137.95M 138.57M 137.08M
Weighted Average Basic & Diluted Shares Outstanding
138.29M 138.01M 137.41M 137.41M 137.53M 138.98M 139.39M 139.39M 139.39M 137.97M 137.79M
Cash Dividends to Common per Share
$0.12 $0.12 $0.12 $0.12 $0.24 $0.24 $0.24 $0.24 $0.24 $0.24 $0.24

Annual Cash Flow Statements for Kennedy-Wilson

This table details how cash moves in and out of Kennedy-Wilson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
-96 -126 -86 -440 391 86 137 -534 154 -206 760
Net Cash From Operating Activities
55 49 33 -30 -13 -20 93 73 103 178 98
Net Cash From Continuing Operating Activities
55 49 33 -30 -13 -20 93 73 103 178 98
Net Income / (Loss) Continuing Operations
-34 -281 102 336 108 321 212 138 77 59 90
Consolidated Net Income / (Loss)
-34 -281 102 336 108 321 212 138 77 59 90
Depreciation Expense
148 158 173 166 180 188 206 213 198 166 105
Amortization Expense
0.80 6.60 3.70 25 -0.90 6.30 0.60 2.50 3.10 0.20 -10
Non-Cash Adjustments To Reconcile Net Income
-70 239 -195 -678 -314 -506 -397 -218 -145 -166 -176
Changes in Operating Assets and Liabilities, net
9.50 -74 -51 120 15 -29 71 -62 -30 118 90
Net Cash From Investing Activities
414 -12 -362 -1,038 591 182 593 -70 -287 -1,484 -2,473
Net Cash From Continuing Investing Activities
414 -12 -362 -1,038 591 182 593 -70 -287 -1,484 -2,473
Purchase of Property, Plant & Equipment
-132 -217 -161 -139 -264 -211 -572 -814 -950 -1,928 -1,962
Acquisitions
-125 -167 -361 -281 -112 -266 -401 -80 -125 -188 -215
Purchase of Investments
-17 -2.10 -419 -1,162 -29 -191 -0.80 -1.20 -11 -10 -14
Sale of Property, Plant & Equipment
590 384 326 486 828 701 1,467 659 540 623 25
Sale and/or Maturity of Investments
138 141 304 141 222 149 88 149 275 256 231
Other Investing Activities, net
-40 -150 -51 -83 -54 0.30 -31 18 -16 -236 -537
Net Cash From Financing Activities
-566 -165 264 632 -207 -86 -529 -565 420 1,119 3,163
Net Cash From Continuing Financing Activities
-566 -165 264 632 -207 -86 -529 -565 420 1,119 3,163
Repayment of Debt
-931 -632 -785 -2,397 -492 -607 -1,326 -1,249 -744 -923 -865
Repurchase of Common Equity
-15 -21 -31 -83 -57 -21 -178 -68 -65 -11 -8.20
Payment of Dividends
-150 -199 -171 -159 -159 -382 -244 -944 -378 -359 -148
Issuance of Debt
531 459 930 3,264 496 614 1,197 1,648 1,565 2,183 2,146
Issuance of Preferred Equity
-0.20 197 297 0.00 0.00 295 0.00 0.00 - - -
Issuance of Common Equity
0.50 31 25 7.80 4.50 15 23 47 42 230 2,038
Effect of Exchange Rate Changes
0.00 2.00 -21 -4.00 20 8.90 -21 28 -82 -20 -29
Cash Interest Paid
256 252 214 184 210 211 225 207 171 134 99
Cash Interest Received
26 24 0.90 -1.20 - - - - - - -
Cash Income Taxes Paid
9.20 22 20 17 13 21 6.60 16 11 3.00 0.30

Quarterly Cash Flow Statements for Kennedy-Wilson

This table details how cash moves in and out of Kennedy-Wilson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
139 -150 0.60 -175 228 -17 -56 38 -90 19 -40
Net Cash From Operating Activities
-52 30 -5.60 37 -5.60 52 -0.40 65 -67 38 17
Net Cash From Continuing Operating Activities
-52 30 -5.60 37 -5.60 52 -0.40 65 -67 38 17
Net Income / (Loss) Continuing Operations
-30 44 -67 -48 38 -236 -64 47 -29 39 24
Consolidated Net Income / (Loss)
-30 44 -67 -48 38 -236 -64 47 -29 39 24
Depreciation Expense
34 36 37 36 39 40 39 40 39 40 46
Amortization Expense
7.00 -5.90 6.40 0.40 -0.10 7.00 -5.00 3.60 1.00 4.50 -0.60
Non-Cash Adjustments To Reconcile Net Income
9.30 -64 33 40 -79 228 64 -61 8.40 -94 -7.50
Changes in Operating Assets and Liabilities, net
-73 19 -15 8.20 -3.10 13 -34 35 -87 48 -45
Net Cash From Investing Activities
-23 156 85 -71 245 8.90 39 -97 37 -2.80 117
Net Cash From Continuing Investing Activities
-23 156 84 -71 245 8.90 39 -97 37 -2.80 117
Purchase of Property, Plant & Equipment
-7.80 -21 -22 -37 -52 -71 -53 -54 -39 -52 -50
Acquisitions
-22 -38 -28 -31 -28 -47 -27 -44 -50 -34 -64
Purchase of Investments
-26 - -9.20 - - -2.10 3.40 - - -10 -54
Sale of Property, Plant & Equipment
13 132 127 2.40 328 101 109 62 112 58 145
Sale and/or Maturity of Investments
31 89 29 14 5.80 51 32 40 18 46 153
Other Investing Activities, net
-11 -5.70 -13 -12 -9.50 -24 -25 -98 -3.50 -12 -14
Net Cash From Financing Activities
219 -328 -86 -142 -9.80 -77 -93 66 -61 -43 -153
Net Cash From Continuing Financing Activities
219 -328 -86 -142 -9.80 -77 -93 66 -61 -43 -153
Repayment of Debt
-4.80 -618 -70 -115 -128 -60 -67 -142 -364 -144 -311
Repurchase of Common Equity
-6.70 - -0.20 -5.70 -9.10 -7.50 - - -13 0.70 -0.80
Payment of Dividends
-30 -30 -29 -45 -46 -47 -61 -42 -49 -41 -52
Issuance of Debt
170 320 14 24 173 38 35 51 335 121 207
Issuance of Common Equity
0.00 0.50 - 0.10 -0.10 0.20 - 1.50 29 20 4.60
Other Financing Activities, net
91 - - - - - - - - - -
Effect of Exchange Rate Changes
-4.90 -7.50 7.50 1.20 -1.20 -0.90 -1.80 3.60 1.10 27 -21
Cash Interest Paid
78 55 82 39 81 75 65 34 78 50 68
Cash Interest Received
3.00 - - - - - - - - - -
Cash Income Taxes Paid
1.80 2.20 4.90 1.00 1.10 5.10 5.30 3.00 8.40 4.70 7.80

Annual Balance Sheets for Kennedy-Wilson

This table presents Kennedy-Wilson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
6,961 7,712 8,272 7,877 7,329 7,305 7,382 7,725 7,657 7,596 6,332
Total Current Assets
256 371 480 561 1,013 626 545 499 1,017 537 544
Cash & Equivalents
218 314 439 525 965 574 488 351 886 183 175
Accounts Receivable
39 57 41 36 48 52 57 63 44 55 56
Plant, Property, & Equipment, net
4,290 4,837 5,188 5,060 4,721 5,080 5,703 6,444 5,814 5,798 0.00
Total Noncurrent Assets
2,415 2,504 2,604 2,256 1,596 1,598 1,135 782 825 1,261 5,789
Long-Term Investments
2,042 2,069 2,238 1,948 1,289 1,327 860 519 556 445 492
Noncurrent Note & Lease Receivables
231 247 149 - 107 - - - - - -
Other Noncurrent Operating Assets
141 188 216 308 199 272 275 263 269 816 5,296
Total Liabilities & Shareholders' Equity
6,961 7,712 8,272 7,877 7,329 7,305 7,382 7,725 7,657 7,596 6,332
Total Liabilities
5,325 5,914 6,261 6,073 5,656 5,585 5,951 6,147 5,314 4,731 3,288
Total Current Liabilities
540 616 674 638 562 538 538 485 423 414 265
Accounts Payable
11 18 16 19 30 20 24 20 11 22 12
Accrued Expenses
529 598 658 619 532 518 514 466 412 392 253
Total Noncurrent Liabilities
4,785 5,298 5,587 5,435 5,095 5,047 5,413 5,662 4,890 4,316 3,000
Long-Term Debt
4,785 5,298 5,587 5,435 5,095 5,047 5,413 5,662 4,890 4,316 3,000
Total Equity & Noncontrolling Interests
1,636 1,798 2,010 1,804 1,673 1,719 1,431 1,578 2,343 2,865 3,044
Total Preferred & Common Equity
1,601 1,755 1,964 1,778 1,645 1,679 1,247 1,366 1,048 1,134 901
Preferred Stock
790 790 593 295 295 295 0.00 - - 0.00 0.00
Total Common Equity
812 965 1,372 1,482 1,349 1,384 1,247 1,366 1,048 1,134 901
Common Stock
1,713 1,719 1,680 1,680 1,725 1,755 1,745 1,883 1,231 1,226 991
Retained Earnings
-494 -349 122 192 18 46 -56 -91 -112 -44 -62
Accumulated Other Comprehensive Income / (Loss)
-408 -404 -430 -390 -394 -417 -442 -427 -71 -48 -28
Noncontrolling Interest
35 43 46 26 28 41 185 212 1,295 1,731 2,143

Quarterly Balance Sheets for Kennedy-Wilson

This table presents Kennedy-Wilson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
7,157 7,444 7,495 7,680 7,910 8,194 8,150 8,085
Total Current Assets
392 410 408 584 378 427 391 458
Cash & Equivalents
357 367 367 542 331 387 349 420
Accounts Receivable
35 43 41 43 47 40 41 38
Plant, Property, & Equipment, net
4,337 4,571 4,605 4,604 4,850 4,982 5,129 5,077
Total Noncurrent Assets
2,429 2,463 2,482 2,492 2,682 2,785 2,631 2,549
Long-Term Investments
2,085 2,053 2,056 2,060 2,233 2,321 2,267 2,130
Noncurrent Note & Lease Receivables
205 248 248 250 238 - - -
Other Noncurrent Operating Assets
139 162 178 182 212 464 363 419
Total Liabilities & Shareholders' Equity
7,157 7,444 7,495 7,680 7,910 8,194 8,150 8,085
Total Liabilities
5,565 5,791 5,785 5,895 5,858 5,993 6,179 6,141
Total Current Liabilities
567 558 563 578 607 659 593 614
Accounts Payable
9.10 9.80 12 16 14 16 13 11
Accrued Expenses
558 548 551 563 593 642 580 603
Total Noncurrent Liabilities
4,998 5,233 5,222 5,317 5,251 5,335 5,586 5,527
Long-Term Debt
4,998 5,233 5,222 5,317 5,251 5,335 5,586 5,527
Total Equity & Noncontrolling Interests
1,592 1,653 1,710 1,785 2,052 2,201 1,971 1,943
Total Preferred & Common Equity
1,558 1,614 1,670 1,743 2,009 2,154 1,925 1,926
Preferred Stock
790 790 790 790 791 791 593 593
Total Common Equity
768 824 880 953 1,218 1,364 1,332 1,334
Common Stock
1,712 1,706 1,701 1,707 1,718 1,711 1,703 1,672
Retained Earnings
-551 -510 -417 -347 -72 53 48 133
Accumulated Other Comprehensive Income / (Loss)
-393 -372 -404 -407 -427 -400 -418 -471
Noncontrolling Interest
34 39 41 42 44 46 47 17

Annual Metrics And Ratios for Kennedy-Wilson

This table displays calculated financial ratios and metrics derived from Kennedy-Wilson's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.55% 4.19% -35.91% 85.59% -39.35% -3.09% -3.67% 16.14% 14.36% 51.46% 223.80%
EBITDA Growth
11.90% 3.55% -63.07% 93.79% -40.31% 21.25% 14.77% 14.69% 10.97% 25.42% 299.65%
EBIT Growth
31.60% 15.62% -78.16% 148.65% -51.21% 34.45% 26.58% 20.31% 4.83% 6.28% 269.64%
NOPAT Growth
25.67% 47.62% -59.52% 655.18% -128.17% 3,934.63% -97.15% -3.28% 81.61% 84.38% 186.89%
Net Income Growth
88.02% -376.15% -69.71% 212.06% -66.43% 51.39% 53.70% 80.39% 29.66% -34.52% 548.20%
EPS Growth
77.24% -623.40% -79.02% 239.39% -58.23% 51.92% 25.30% 8,200.00% -98.48% 371.43% 166.67%
Operating Cash Flow Growth
12.68% 48.63% 208.58% -140.48% 35.38% -120.95% 27.53% -29.06% -42.26% 81.65% 213.42%
Free Cash Flow Firm Growth
113.53% 595.57% -66.15% -112.89% -58.97% -12.49% 291.11% -151.84% 181.42% 76.84% -3,511.97%
Invested Capital Growth
-11.72% -4.20% 3.22% 5.62% -7.25% -11.47% -13.70% 9.96% -11.63% 21.36% 701.96%
Revenue Q/Q Growth
103.76% -14.52% -36.31% 46.95% -13.24% -0.17% -0.32% 1.74% 0.17% 2.24% 51.96%
EBITDA Q/Q Growth
1,546.12% -24.97% -47.09% -5.67% -18.02% 68.86% -16.35% 11.06% 2.00% 24.74% -0.09%
EBIT Q/Q Growth
263.71% -39.48% -65.95% -6.61% -25.94% 118.95% -20.62% 13.40% 5.38% 29.94% -7.42%
NOPAT Q/Q Growth
197.19% 52.60% -64.53% 477.19% -122.85% 288.06% -94.65% -20.24% 21.63% 170.14% 26.71%
Net Income Q/Q Growth
89.24% -4,366.67% -4.77% -27.59% 14.44% 64.58% -25.50% 77.84% 28.14% 478.43% -29.94%
EPS Q/Q Growth
78.29% -392.00% -17.54% 0.00% 0.00% 135.82% -37.72% 538.46% -94.74% 3,200.00% -60.00%
Operating Cash Flow Q/Q Growth
-28.53% 40.11% -33.80% 67.03% -186.30% 48.95% 164.49% -52.63% -27.74% 40.76% -26.85%
Free Cash Flow Firm Q/Q Growth
554.02% 26.49% -54.86% -177.77% -27.22% 17.43% -38.64% -696.22% 307.89% 48.73% -35.70%
Invested Capital Q/Q Growth
-6.83% -0.55% 0.00% 2.87% -2.92% -0.96% -2.52% -9.05% -14.78% 4.52% 30.86%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.98% 41.36% 40.56% 63.45% 42.42% 55.31% 34.04% 35.63% 35.07% 59.47% 57.12%
EBITDA Margin
71.87% 60.66% 61.04% 105.91% 101.43% 103.07% 82.38% 69.14% 70.02% 72.16% 87.13%
Operating Margin
43.02% 32.33% 21.65% 34.77% -11.87% 20.55% 0.56% 13.02% 20.97% 21.27% 12.47%
EBIT Margin
43.81% 31.44% 28.33% 83.16% 62.07% 77.17% 55.62% 42.33% 40.86% 44.58% 63.52%
Profit (Net Income) Margin
-6.34% -50.02% 18.87% 39.92% 23.74% 42.90% 27.46% 17.21% 11.08% 9.77% 22.60%
Tax Burden Percent
143.40% 83.58% 73.79% 72.72% 71.20% 88.58% 78.53% 113.39% 84.53% 52.49% 73.55%
Interest Burden Percent
-10.09% -190.33% 90.26% 66.02% 53.73% 62.76% 62.87% 35.86% 32.08% 41.77% 48.38%
Effective Tax Rate
0.00% 0.00% 26.21% 27.28% 28.80% 11.42% 21.47% -13.39% 15.47% 47.51% 26.45%
Return on Invested Capital (ROIC)
3.61% 2.64% 1.78% 4.59% -0.82% 2.63% 0.06% 1.95% 1.98% 1.13% 1.20%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.52% -11.39% 2.31% 8.84% 4.07% 7.76% 4.77% 2.42% 0.70% 0.85% 6.05%
Return on Net Nonoperating Assets (RNNOA)
-5.57% -17.42% 3.56% 14.76% 7.17% 17.76% 14.04% 5.09% 0.95% 0.87% 3.46%
Return on Equity (ROE)
-1.96% -14.78% 5.34% 19.35% 6.36% 20.38% 14.10% 7.04% 2.94% 2.00% 4.67%
Cash Return on Invested Capital (CROIC)
16.06% 6.93% -1.39% -0.87% 6.71% 14.80% 14.77% -7.54% 14.33% -18.17% -154.45%
Operating Return on Assets (OROA)
3.17% 2.21% 1.89% 9.22% 3.85% 7.87% 5.69% 4.41% 3.70% 3.86% 6.23%
Return on Assets (ROA)
-0.46% -3.52% 1.26% 4.42% 1.47% 4.37% 2.81% 1.79% 1.00% 0.85% 2.22%
Return on Common Equity (ROCE)
-1.02% -9.07% 4.00% 15.76% 5.12% 17.02% 12.24% 4.33% 1.23% 0.69% 2.02%
Return on Equity Simple (ROE_SIMPLE)
-2.10% -16.03% 5.19% 18.92% 6.56% 19.13% 17.01% 10.11% 7.30% 5.20% 10.00%
Net Operating Profit after Tax (NOPAT)
160 127 86 213 -38 136 3.38 118 122 67 37
NOPAT Margin
30.11% 22.63% 15.97% 25.29% -8.45% 18.20% 0.44% 14.76% 17.73% 11.16% 9.17%
Net Nonoperating Expense Percent (NNEP)
7.12% 14.03% -0.53% -4.25% -4.88% -5.13% -4.71% -0.48% 1.29% 0.28% -4.84%
Return On Investment Capital (ROIC_SIMPLE)
2.49% 1.79% 1.14% - - - - - - - -
Cost of Revenue to Revenue
55.02% 58.64% 59.44% 36.55% 57.58% 44.69% 65.96% 64.37% 64.93% 40.53% 42.88%
SG&A Expenses to Revenue
7.30% 6.35% 6.89% 3.95% 7.62% 5.66% 6.58% 5.26% 6.58% 7.26% 10.56%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
1.96% 9.03% 18.91% 28.67% 54.30% 34.76% 33.48% 22.61% 14.09% 38.20% 44.66%
Earnings before Interest and Taxes (EBIT)
233 177 153 701 282 578 430 339 282 269 253
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
382 341 330 892 461 772 636 554 483 436 347
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.69 1.67 1.39 1.91 1.53 1.77 1.55 1.37 1.52 1.62 1.73
Price to Tangible Book Value (P/TBV)
1.69 1.67 1.39 1.91 1.53 1.77 1.55 1.37 1.52 1.62 1.73
Price to Revenue (P/Rev)
2.58 2.87 3.52 3.36 4.56 3.27 2.51 2.33 2.30 3.04 3.91
Price to Earnings (P/E)
0.00 0.00 29.35 9.04 22.28 10.91 12.92 18.57 567.82 25.81 112.99
Dividend Yield
6.01% 8.28% 6.96% 4.43% 6.03% 4.95% 5.80% 5.68% 3.99% 3.62% 2.31%
Earnings Yield
0.00% 0.00% 3.41% 11.06% 4.49% 9.17% 7.74% 5.39% 0.18% 3.87% 0.89%
Enterprise Value to Invested Capital (EV/IC)
1.13 1.14 1.11 1.28 1.16 1.22 1.13 1.08 1.09 1.11 1.12
Enterprise Value to Revenue (EV/Rev)
8.89 9.54 10.09 7.26 11.53 7.92 8.01 8.57 9.17 12.02 15.14
Enterprise Value to EBITDA (EV/EBITDA)
12.37 15.72 16.54 6.85 11.36 7.68 9.72 12.39 13.10 16.66 17.38
Enterprise Value to EBIT (EV/EBIT)
20.28 30.33 35.62 8.73 18.57 10.26 14.40 20.24 22.45 26.96 23.84
Enterprise Value to NOPAT (EV/NOPAT)
29.51 42.13 63.18 28.70 0.00 43.50 1,832.27 58.03 51.75 107.64 165.10
Enterprise Value to Operating Cash Flow (EV/OCF)
85.70 109.70 165.66 0.00 0.00 0.00 66.45 94.10 61.55 40.71 61.52
Enterprise Value to Free Cash Flow (EV/FCFF)
6.63 16.07 0.00 0.00 16.64 7.73 7.06 0.00 7.16 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.92 2.95 2.78 3.01 3.05 2.94 3.78 3.59 2.09 1.51 0.99
Long-Term Debt to Equity
2.92 2.95 2.78 3.01 3.05 2.94 3.78 3.59 2.09 1.51 0.99
Financial Leverage
1.58 1.53 1.54 1.67 1.77 2.29 2.94 2.10 1.37 1.02 0.57
Leverage Ratio
4.27 4.20 4.23 4.37 4.31 4.66 5.02 3.92 2.93 2.36 2.10
Compound Leverage Factor
-0.43 -7.99 3.82 2.89 2.32 2.93 3.16 1.41 0.94 0.98 1.02
Debt to Total Capital
74.52% 74.66% 73.54% 75.08% 75.28% 74.59% 79.09% 78.21% 67.61% 60.10% 49.64%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
74.52% 74.66% 73.54% 75.08% 75.28% 74.59% 79.09% 78.21% 67.61% 60.10% 49.64%
Preferred Equity to Total Capital
12.30% 11.13% 7.80% 4.08% 4.36% 4.36% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.54% 0.61% 0.61% 0.36% 0.42% 0.60% 2.70% 2.93% 17.90% 24.11% 35.45%
Common Equity to Total Capital
12.64% 13.60% 18.05% 20.48% 19.94% 20.45% 18.22% 18.86% 14.49% 15.79% 14.91%
Debt to EBITDA
12.53 15.52 16.95 6.09 11.06 6.54 8.51 10.21 10.12 9.91 8.64
Net Debt to EBITDA
6.61 8.54 8.83 3.32 6.17 4.08 6.39 8.64 7.13 8.47 6.72
Long-Term Debt to EBITDA
12.53 15.52 16.95 6.09 11.06 6.54 8.51 10.21 10.12 9.91 8.64
Debt to NOPAT
29.90 41.61 64.77 25.51 -132.75 37.05 1,603.01 47.83 39.95 64.04 82.07
Net Debt to NOPAT
15.78 22.89 33.73 13.90 -74.00 23.10 1,203.83 40.47 28.18 54.73 63.83
Long-Term Debt to NOPAT
29.90 41.61 64.77 25.51 -132.75 37.05 1,603.01 47.83 39.95 64.04 82.07
Altman Z-Score
0.19 0.21 0.30 0.70 0.49 0.65 0.48 0.42 0.46 0.44 0.52
Noncontrolling Interest Sharing Ratio
48.27% 38.65% 25.18% 18.55% 19.43% 16.51% 13.18% 38.44% 58.11% 65.56% 56.78%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.47 0.60 0.71 0.88 1.80 1.16 1.01 1.03 2.40 1.30 2.05
Quick Ratio
0.47 0.60 0.71 0.88 1.80 1.16 1.01 1.03 2.40 1.30 2.05
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
713 334 -67 -41 315 767 876 -458 884 -1,086 -4,690
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 47.04% 25.13% 13.66% 5.06%
Free Cash Flow to Firm to Interest Expense
2.71 1.28 -0.35 -0.89 1.49 3.56 3.68 -2.11 4.62 -6.93 -55.57
Operating Cash Flow to Interest Expense
0.21 0.19 0.17 -0.66 -0.06 -0.09 0.39 0.34 0.54 1.14 1.16
Operating Cash Flow Less CapEx to Interest Expense
1.95 0.83 1.02 6.93 2.61 2.19 4.15 -0.38 -1.60 -7.19 -21.79
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.07 0.07 0.07 0.11 0.06 0.10 0.10 0.10 0.09 0.09 0.10
Accounts Receivable Turnover
11.07 11.47 14.04 20.06 9.08 13.77 12.95 15.03 13.99 10.95 11.04
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.12 0.11 0.11 0.17 0.09 0.14 0.13 0.13 0.12 0.00 0.00
Accounts Payable Turnover
20.38 19.35 18.45 12.65 10.35 15.03 23.37 33.62 26.84 14.44 2.43
Days Sales Outstanding (DSO)
32.97 31.82 25.99 18.19 40.20 26.50 28.19 24.29 26.09 33.34 33.06
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
17.91 18.86 19.79 28.86 35.26 24.28 15.62 10.86 13.60 25.28 150.36
Cash Conversion Cycle (CCC)
15.06 12.96 6.20 -10.66 4.94 2.22 12.57 13.43 12.49 8.06 -117.30
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,161 4,714 4,920 4,766 4,513 4,866 5,496 6,369 5,792 6,554 5,400
Invested Capital Turnover
0.12 0.12 0.11 0.18 0.10 0.14 0.13 0.13 0.11 0.10 0.13
Increase / (Decrease) in Invested Capital
-553 -206 154 254 -353 -630 -873 577 -762 1,154 4,727
Enterprise Value (EV)
4,722 5,364 5,450 6,116 5,233 5,927 6,187 6,869 6,334 7,255 6,035
Market Capitalization
1,373 1,616 1,902 2,832 2,070 2,445 1,938 1,866 1,590 1,835 1,559
Book Value per Share
$5.91 $6.92 $9.95 $10.64 $9.52 $9.71 $8.65 $9.02 $9.25 $9.90 $9.50
Tangible Book Value per Share
$5.91 $6.92 $9.95 $10.64 $9.52 $9.71 $8.65 $9.02 $9.25 $9.90 $9.50
Total Capital
6,421 7,096 7,597 7,239 6,767 6,766 6,844 7,239 7,233 7,181 6,044
Total Debt
4,785 5,298 5,587 5,435 5,095 5,047 5,413 5,662 4,890 4,316 3,000
Total Long-Term Debt
4,785 5,298 5,587 5,435 5,095 5,047 5,413 5,662 4,890 4,316 3,000
Net Debt
2,525 2,915 2,910 2,963 2,840 3,147 4,065 4,791 3,449 3,689 2,333
Capital Expenditures (CapEx)
-458 -167 -165 -347 -564 -490 -895 155 410 1,305 1,938
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-502 -558 -634 -602 -514 -486 -481 -338 -292 -60 104
Debt-free Net Working Capital (DFNWC)
-284 -245 -194 -77 451 88 6.80 13 594 123 279
Net Working Capital (NWC)
-284 -245 -194 -77 451 88 6.80 13 594 123 279
Net Nonoperating Expense (NNE)
194 409 -16 -123 -146 -185 -209 -20 46 8.40 -54
Net Nonoperating Obligations (NNO)
2,525 2,915 2,910 2,963 2,840 3,147 4,065 4,791 3,449 3,689 2,357
Total Depreciation and Amortization (D&A)
149 164 177 192 179 194 207 215 201 167 94
Debt-free, Cash-free Net Working Capital to Revenue
-94.37% -99.25% -117.33% -71.40% -113.19% -64.97% -62.30% -42.16% -42.24% -9.91% 26.12%
Debt-free Net Working Capital to Revenue
-53.44% -43.49% -35.98% -9.11% 99.38% 11.70% 0.88% 1.66% 86.05% 20.34% 69.92%
Net Working Capital to Revenue
-53.44% -43.49% -35.98% -9.11% 99.38% 11.70% 0.88% 1.66% 86.05% 20.34% 69.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.56) ($2.46) $0.47 $2.26 $0.66 $1.60 $1.04 $0.00 $0.01 $0.66 $0.14
Adjusted Weighted Average Basic Shares Outstanding
137.78M 138.93M 136.90M 138.55M 139.74M 139.73M 142.90M 0.00 109.09M 103.26M 89.20M
Adjusted Diluted Earnings per Share
($0.56) ($2.46) $0.47 $2.24 $0.66 $1.58 $1.04 $0.00 $0.01 $0.66 $0.14
Adjusted Weighted Average Diluted Shares Outstanding
137.78M 138.93M 138.57M 140.13M 140.35M 141.50M 144.75M 0.00 109.09M 109.55M 91.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
138.01M 138.98M 137.97M 137.87M 141.08M 142.17M 142.98M 0.00 114.90M 114.41M 96.01M
Normalized Net Operating Profit after Tax (NOPAT)
48 38 9.74 213 -38 136 4.71 22 -1.27 16 -3.31
Normalized NOPAT Margin
9.02% 6.76% 1.80% 25.29% -8.45% 18.20% 0.61% 2.71% -0.18% 2.70% -0.83%
Pre Tax Income Margin
-4.42% -59.85% 25.57% 54.90% 33.35% 48.43% 34.97% 15.18% 13.11% 18.62% 30.73%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.89 0.68 0.79 15.33 1.33 2.69 1.80 1.56 1.47 1.72 3.00
NOPAT to Interest Expense
0.61 0.49 0.45 4.66 -0.18 0.63 0.01 0.54 0.64 0.43 0.43
EBIT Less CapEx to Interest Expense
2.63 1.32 1.65 22.93 4.00 4.96 5.56 0.85 -0.66 -6.61 -19.96
NOPAT Less CapEx to Interest Expense
2.35 1.13 1.30 12.26 2.49 2.91 3.77 -0.17 -1.50 -7.90 -22.52
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-445.70% -70.79% 168.11% 47.38% 147.12% 118.81% 115.23% 684.13% 494.51% 609.15% 163.82%
Augmented Payout Ratio
-490.21% -78.22% 198.72% 72.12% 200.37% 125.26% 199.10% 733.19% 579.22% 628.47% 172.92%

Quarterly Metrics And Ratios for Kennedy-Wilson

This table displays calculated financial ratios and metrics derived from Kennedy-Wilson's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.94% 11.70% -11.34% -21.50% -1.23% 119.31% -5.33% -13.01% -20.01% -81.61% -41.01%
EBITDA Growth
-67.53% 751.06% -39.57% -75.74% 139.43% 127.81% -37.62% 75.68% -50.95% -120.89% -25.22%
EBIT Growth
-88.56% 377.16% -81.62% -96.65% 335.14% 66.04% -43.27% 132.90% -70.01% -147.49% -35.38%
NOPAT Growth
-80.77% 127.52% -56.98% -73.72% -2.64% 380.66% 169.05% -63.24% -87.58% -120.26% -85.07%
Net Income Growth
-178.51% 118.52% -4.21% -202.11% 231.36% -701.79% -371.61% 5,355.56% -171.75% -11.51% -67.45%
EPS Growth
-257.89% 113.48% 15.15% -253.57% 163.33% -1,088.89% -650.00% 500.00% -225.00% -35.71% -74.47%
Operating Cash Flow Growth
-826.79% -42.64% -1,300.00% -43.28% 91.64% 37.23% -102.38% 72.99% -13.75% -30.88% 191.30%
Free Cash Flow Firm Growth
-28.99% 157.34% 32.93% 30.03% 638.52% 255.30% 179.93% 134.36% 77.35% -41.05% -350.68%
Invested Capital Growth
-7.81% -11.72% -5.77% -6.59% -8.91% -4.20% -3.67% -4.67% 1.91% 3.22% 6.19%
Revenue Q/Q Growth
-24.53% 33.33% 11.94% -5.08% 249.63% 5.84% -0.90% 19.42% -50.97% -54.31% -8.93%
EBITDA Q/Q Growth
-52.83% 125.14% 30.00% -75.54% 201.76% -84.01% -47.81% 141.43% -45.18% -135.86% 46.99%
EBIT Q/Q Growth
-82.74% 798.00% 138.10% -96.74% 160.98% -159.56% -56.58% 323.31% -64.34% -199.48% 78.25%
NOPAT Q/Q Growth
-91.15% 912.50% 524.32% -71.64% 107.64% 91.43% 281.46% 5.06% -68.43% -283.52% -47.89%
Net Income Q/Q Growth
-167.73% 165.42% -38.30% -228.12% 115.98% -268.02% -235.52% 264.81% -173.21% 66.10% 2,722.22%
EPS Q/Q Growth
-225.00% 142.86% -30.23% -326.32% 110.67% -169.70% -335.71% 193.33% -266.67% 50.00% 271.43%
Operating Cash Flow Q/Q Growth
-275.34% 628.57% -115.26% 755.36% -110.85% 13,000.00% -100.62% 196.57% -278.19% 123.81% -55.08%
Free Cash Flow Firm Q/Q Growth
-48.91% 147.20% -9.61% -28.64% 416.89% 27.69% -11.59% 395.56% 32.66% 34.28% 61.99%
Invested Capital Q/Q Growth
-0.29% -6.83% -0.96% 0.20% -4.52% -0.55% -1.82% -2.29% 0.42% 0.00% -2.85%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
49.34% 45.94% 45.88% 39.60% 47.75% 30.03% 44.85% 41.14% 51.69% -146.97% 46.68%
EBITDA Margin
44.12% 70.59% 41.80% 36.00% 139.67% 9.26% 61.34% 116.47% 57.61% -73.05% 93.09%
Operating Margin
16.13% 109.53% 18.12% 3.25% 13.00% 67.54% 37.34% 8.27% 11.03% -49.86% 14.61%
EBIT Margin
12.08% 52.82% 7.84% 3.69% 107.33% -21.29% 37.83% 86.35% 24.36% -137.46% 63.13%
Profit (Net Income) Margin
-23.07% 25.71% -52.39% -42.41% 31.42% -154.99% -44.58% 32.60% -23.62% 56.48% 15.54%
Tax Burden Percent
85.80% 87.93% 86.19% 80.37% 58.54% 84.89% 76.49% 82.12% 88.04% 74.10% 62.93%
Interest Burden Percent
-222.58% 55.35% -775.00% -1,430.95% 50.00% 857.72% -154.04% 45.97% -110.14% -55.45% 39.10%
Effective Tax Rate
0.00% 12.07% 0.00% 0.00% 41.46% 0.00% 0.00% 17.88% 0.00% 25.90% 37.07%
Return on Invested Capital (ROIC)
1.37% 11.53% 0.72% 0.14% 0.50% 5.52% 3.56% 0.91% 1.09% -4.12% 1.63%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.31% 7.12% -2.30% -1.74% 1.50% -5.05% -0.03% 2.23% -0.24% -1.91% 1.97%
Return on Net Nonoperating Assets (RNNOA)
-0.48% 11.28% -3.41% -2.42% 2.27% -7.72% -0.04% 3.03% -0.34% -2.94% 3.01%
Return on Equity (ROE)
0.89% 22.81% -2.69% -2.28% 2.77% -2.20% 3.52% 3.95% 0.75% -7.06% 4.64%
Cash Return on Invested Capital (CROIC)
10.08% 16.06% 2.37% 3.74% 6.41% 6.93% 5.46% 6.04% -0.55% -1.39% -0.91%
Operating Return on Assets (OROA)
0.85% 3.83% 0.27% 0.13% 4.18% -1.50% 3.11% 6.97% 2.07% -9.19% 6.75%
Return on Assets (ROA)
-1.63% 1.86% -1.78% -1.50% 1.22% -10.91% -3.67% 2.63% -2.00% 3.78% 1.66%
Return on Common Equity (ROCE)
0.45% 11.80% -1.48% -1.31% 1.69% -1.35% 2.25% 2.58% 0.51% -5.28% 3.49%
Return on Equity Simple (ROE_SIMPLE)
-6.48% 0.00% -19.42% -18.60% -12.34% 0.00% -0.31% 3.78% 1.72% 0.00% 5.55%
Net Operating Profit after Tax (NOPAT)
14 164 16 2.59 9.13 72 38 9.85 9.38 -26 14
NOPAT Margin
11.29% 96.31% 12.68% 2.27% 7.61% 47.28% 26.14% 6.79% 7.72% -36.94% 9.20%
Net Nonoperating Expense Percent (NNEP)
1.67% 4.41% 3.02% 1.88% -1.01% 10.57% 3.59% -1.31% 1.32% -2.21% -0.33%
Return On Investment Capital (ROIC_SIMPLE)
0.22% 2.55% - - - 1.01% - - - -0.34% -
Cost of Revenue to Revenue
50.66% 54.06% 54.12% 60.40% 52.25% 69.97% 55.15% 58.86% 48.31% 246.97% 53.32%
SG&A Expenses to Revenue
8.11% 6.35% 8.00% 8.34% 6.92% 6.70% 5.84% 6.00% 6.91% 15.42% 6.06%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
33.20% -63.59% 27.76% 36.35% 34.75% -37.52% 7.51% 32.87% 40.66% -97.12% 32.06%
Earnings before Interest and Taxes (EBIT)
16 90 10 4.20 129 -32 54 125 30 -95 96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
57 120 53 41 168 14 88 169 70 -51 141
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.56 1.69 1.84 1.52 0.00 1.67 1.57 1.54 1.57 1.39 1.41
Price to Tangible Book Value (P/TBV)
1.56 1.69 1.84 1.52 0.00 1.67 1.57 1.54 1.57 1.39 1.41
Price to Revenue (P/Rev)
2.29 2.58 5.82 4.82 0.00 2.87 2.90 3.16 3.03 3.52 2.22
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 56.59 0.00 29.35 23.62
Dividend Yield
5.53% 6.01% 6.52% 8.64% 11.33% 8.28% 7.00% 6.36% 6.35% 6.96% 7.03%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.77% 0.00% 3.41% 4.23%
Enterprise Value to Invested Capital (EV/IC)
1.10 1.13 1.16 1.10 0.00 1.14 1.15 1.15 1.15 1.11 1.11
Enterprise Value to Revenue (EV/Rev)
8.75 8.89 19.79 17.92 0.00 9.54 8.25 8.36 8.28 10.09 6.45
Enterprise Value to EBITDA (EV/EBITDA)
17.33 12.37 222.44 85.48 0.00 15.72 11.94 10.96 13.08 16.54 8.78
Enterprise Value to EBIT (EV/EBIT)
40.59 20.28 0.00 0.00 0.00 30.33 18.58 16.68 21.71 35.62 12.17
Enterprise Value to NOPAT (EV/NOPAT)
54.24 29.51 0.00 0.00 0.00 42.13 65.10 90.02 86.20 63.18 22.48
Enterprise Value to Operating Cash Flow (EV/OCF)
520.30 85.70 66.93 60.35 0.00 109.70 155.64 106.88 229.57 165.66 110.03
Enterprise Value to Free Cash Flow (EV/FCFF)
10.50 6.63 47.36 28.42 0.00 16.07 20.59 18.65 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.14 2.92 3.17 3.05 2.98 2.95 2.56 2.42 2.83 2.78 2.84
Long-Term Debt to Equity
3.14 2.92 3.17 3.05 2.98 2.95 2.56 2.42 2.83 2.78 2.84
Financial Leverage
1.56 1.58 1.48 1.39 1.51 1.53 1.42 1.36 1.43 1.54 1.53
Leverage Ratio
4.39 4.27 4.14 4.01 4.21 4.20 4.00 3.94 4.02 4.23 4.20
Compound Leverage Factor
-9.78 2.36 -32.12 -57.40 2.11 35.99 -6.17 1.81 -4.43 -2.35 1.64
Debt to Total Capital
75.84% 74.52% 76.00% 75.33% 74.87% 74.66% 71.90% 70.80% 73.91% 73.54% 73.99%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
75.84% 74.52% 76.00% 75.33% 74.87% 74.66% 71.90% 70.80% 73.91% 73.54% 73.99%
Preferred Equity to Total Capital
11.98% 12.30% 11.47% 11.40% 11.12% 11.13% 10.82% 10.49% 7.84% 7.80% 7.93%
Noncontrolling Interests to Total Capital
0.52% 0.54% 0.57% 0.59% 0.60% 0.61% 0.60% 0.61% 0.62% 0.61% 0.22%
Common Equity to Total Capital
11.66% 12.64% 11.96% 12.69% 13.41% 13.60% 16.68% 18.10% 17.63% 18.05% 17.86%
Debt to EBITDA
18.92 12.53 225.57 89.87 28.57 15.52 11.54 10.50 12.83 16.95 8.87
Net Debt to EBITDA
9.68 6.61 121.26 48.18 14.59 8.54 5.91 5.17 6.82 8.83 4.78
Long-Term Debt to EBITDA
18.92 12.53 225.57 89.87 28.57 15.52 11.54 10.50 12.83 16.95 8.87
Debt to NOPAT
59.21 29.90 -31.79 -36.46 -38.70 41.61 62.93 86.24 84.57 64.77 22.73
Net Debt to NOPAT
30.29 15.78 -17.09 -19.54 -19.76 22.89 32.21 42.46 44.95 33.73 12.24
Long-Term Debt to NOPAT
59.21 29.90 -31.79 -36.46 -38.70 41.61 62.93 86.24 84.57 64.77 22.73
Altman Z-Score
0.07 0.13 0.08 0.07 0.00 0.12 0.25 0.32 0.28 0.20 0.33
Noncontrolling Interest Sharing Ratio
49.04% 48.27% 44.89% 42.64% 39.17% 38.65% 36.13% 34.70% 31.18% 25.18% 24.83%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.69 0.47 0.73 0.72 1.01 0.60 0.62 0.65 0.66 0.71 0.75
Quick Ratio
0.69 0.47 0.73 0.72 1.01 0.60 0.62 0.65 0.66 0.71 0.75
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
366 716 290 321 449 278 218 247 -83 -179 -273
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 105.46% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
5.96 3.67 4.31 641.18 0.00 1.43 3.40 145.03 0.00 -0.94 -209.79
Operating Cash Flow to Interest Expense
-0.85 0.15 -0.08 73.40 0.00 0.26 -0.01 38.06 0.00 0.20 12.92
Operating Cash Flow Less CapEx to Interest Expense
-0.76 0.72 1.48 3.80 0.00 0.42 0.86 42.71 0.00 0.23 86.46
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.07 0.07 0.03 0.04 0.04 0.07 0.08 0.08 0.08 0.07 0.11
Accounts Receivable Turnover
13.50 11.07 5.77 6.81 7.35 11.47 15.40 16.19 17.09 14.04 20.86
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.12 0.12 0.06 0.06 0.06 0.11 0.13 0.13 0.14 0.11 0.17
Accounts Payable Turnover
23.17 20.38 25.80 22.42 23.43 19.35 31.71 23.67 26.91 18.45 21.13
Days Sales Outstanding (DSO)
27.03 32.97 63.26 53.61 49.67 31.82 23.71 22.54 21.35 25.99 17.50
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
15.75 17.91 14.15 16.28 15.58 18.86 11.51 15.42 13.56 19.79 17.27
Cash Conversion Cycle (CCC)
11.28 15.06 49.11 37.33 34.09 12.96 12.20 7.12 7.79 6.20 0.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,149 4,161 4,466 4,509 4,501 4,714 4,740 4,827 4,941 4,920 4,920
Invested Capital Turnover
0.12 0.12 0.06 0.06 0.07 0.12 0.14 0.13 0.14 0.11 0.18
Increase / (Decrease) in Invested Capital
-352 -553 -274 -318 -440 -206 -180 -237 93 154 287
Enterprise Value (EV)
4,579 4,722 5,161 4,967 0.00 5,364 5,432 5,568 5,693 5,450 5,469
Market Capitalization
1,198 1,373 1,518 1,337 0.00 1,616 1,910 2,105 2,085 1,902 1,882
Book Value per Share
$5.57 $5.91 $6.00 $6.40 $6.88 $6.92 $8.74 $9.78 $9.66 $9.95 $9.68
Tangible Book Value per Share
$5.57 $5.91 $6.00 $6.40 $6.88 $6.92 $8.74 $9.78 $9.66 $9.95 $9.68
Total Capital
6,590 6,421 6,886 6,932 7,102 7,096 7,303 7,535 7,557 7,597 7,471
Total Debt
4,998 4,785 5,233 5,222 5,317 5,298 5,251 5,335 5,586 5,587 5,527
Total Long-Term Debt
4,998 4,785 5,233 5,222 5,317 5,298 5,251 5,335 5,586 5,587 5,527
Net Debt
2,557 2,525 2,813 2,799 2,716 2,915 2,687 2,627 2,969 2,910 2,977
Capital Expenditures (CapEx)
-5.30 -111 -105 35 -277 -31 -56 -7.90 -73 -6.60 -96
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-532 -502 -515 -522 -536 -558 -560 -619 -551 -634 -576
Debt-free Net Working Capital (DFNWC)
-175 -284 -148 -156 6.10 -245 -229 -232 -202 -194 -156
Net Working Capital (NWC)
-175 -284 -148 -156 6.10 -245 -229 -232 -202 -194 -156
Net Nonoperating Expense (NNE)
44 120 83 51 -29 308 102 -37 38 -65 -9.63
Net Nonoperating Obligations (NNO)
2,557 2,525 2,813 2,799 2,716 2,915 2,687 2,627 2,969 2,910 2,977
Total Depreciation and Amortization (D&A)
41 30 43 37 39 47 34 44 40 45 46
Debt-free, Cash-free Net Working Capital to Revenue
-101.62% -94.37% -197.55% -188.38% -173.79% -99.25% -85.03% -92.84% -80.13% -117.33% -67.91%
Debt-free Net Working Capital to Revenue
-33.48% -53.44% -56.79% -56.12% 1.98% -43.49% -34.76% -34.76% -29.36% -35.98% -18.34%
Net Working Capital to Revenue
-33.48% -53.44% -56.79% -56.12% 1.98% -43.49% -34.76% -34.76% -29.36% -35.98% -18.34%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.30) $0.24 ($0.56) ($0.43) $0.19 ($1.78) ($0.66) $0.28 ($0.30) $0.17 $0.12
Adjusted Weighted Average Basic Shares Outstanding
137.75M 137.78M 137.41M 137.59M 138.47M 138.93M 139.39M 139.39M 137.95M 136.90M 136.84M
Adjusted Diluted Earnings per Share
($0.30) $0.24 ($0.56) ($0.43) $0.19 ($1.78) ($0.66) $0.28 ($0.30) $0.18 $0.12
Adjusted Weighted Average Diluted Shares Outstanding
137.75M 137.78M 137.41M 137.59M 138.63M 138.93M 139.39M 139.55M 137.95M 138.57M 137.08M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
138.29M 138.01M 137.41M 137.41M 137.53M 138.98M 139.39M 139.39M 139.39M 137.97M 137.79M
Normalized Net Operating Profit after Tax (NOPAT)
15 164 12 2.59 9.13 72 16 9.85 9.38 -26 14
Normalized NOPAT Margin
11.73% 96.31% 9.28% 2.27% 7.61% 47.28% 11.34% 6.79% 7.72% -36.94% 9.20%
Pre Tax Income Margin
-26.89% 29.24% -60.78% -52.77% 53.67% -182.59% -58.28% 39.70% -26.83% 76.22% 24.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.25 0.46 0.15 8.40 0.00 -0.17 0.85 73.71 0.00 -0.50 73.77
NOPAT to Interest Expense
0.24 0.84 0.24 5.18 0.00 0.37 0.59 5.80 0.00 -0.13 10.75
EBIT Less CapEx to Interest Expense
0.34 1.03 1.71 -61.20 0.00 -0.01 1.71 78.35 0.00 -0.47 147.31
NOPAT Less CapEx to Interest Expense
0.32 1.41 1.80 -64.42 0.00 0.53 1.45 10.44 0.00 -0.10 84.29
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-133.27% -445.70% -53.50% -64.23% -91.40% -70.79% -3,060.32% 225.31% 539.16% 168.11% 165.42%
Augmented Payout Ratio
-145.74% -490.21% -60.68% -71.41% -99.12% -78.22% -3,261.90% 241.89% 579.82% 198.72% 230.28%

Frequently Asked Questions About Kennedy-Wilson's Financials

When does Kennedy-Wilson's financial year end?

According to the most recent income statement we have on file, Kennedy-Wilson's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Kennedy-Wilson's net income changed over the last 10 years?

Kennedy-Wilson's net income appears to be on a downward trend, with a most recent value of -$33.70 million in 2024, falling from $90.10 million in 2014. The previous period was -$281.40 million in 2023. Check out Kennedy-Wilson's forecast to explore projected trends and price targets.

What is Kennedy-Wilson's operating income?
Kennedy-Wilson's total operating income in 2024 was $228.60 million, based on the following breakdown:
  • Total Gross Profit: $239 million
  • Total Operating Expenses: $10.40 million
How has Kennedy-Wilson revenue changed over the last 10 years?

Over the last 10 years, Kennedy-Wilson's total revenue changed from $398.60 million in 2014 to $531.40 million in 2024, a change of 33.3%.

How much debt does Kennedy-Wilson have?

Kennedy-Wilson's total liabilities were at $5.33 billion at the end of 2024, a 10.0% decrease from 2023, and a 61.9% increase since 2014.

How much cash does Kennedy-Wilson have?

In the past 10 years, Kennedy-Wilson's cash and equivalents has ranged from $174.60 million in 2014 to $965.10 million in 2020, and is currently $217.50 million as of their latest financial filing in 2024.

How has Kennedy-Wilson's book value per share changed over the last 10 years?

Over the last 10 years, Kennedy-Wilson's book value per share changed from 9.50 in 2014 to 5.91 in 2024, a change of -37.9%.



This page (NYSE:KW) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners